μ Opioid Receptor A118G Polymorphism in Association with Striatal Opioid Neuropeptide Gene Expression in Heroin Abusers

μ Opioid receptors are critical for heroin dependence, and A118G SNP of the μ opioid receptor gene (OPRM1) has been linked with heroin abuse. In our population of European Caucasians (n = 118), ≈90% of 118G allelic carriers were heroin users. Postmortem brain analyses showed the OPRM1 genotype assoc...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 103; no. 20; pp. 7883 - 7888
Main Authors: Drakenberg, Katarina, Nikoshkov, Andrej, Horváth, Monika Cs, Fagergren, Pernilla, Gharibyan, Anna, Saarelainen, Kati, Rahman, Sadia, Nylander, Ingrid, Bakalkin, Georgy, Rajs, Jovan, Keller, Eva, Hurd, Yasmin L.
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 16-05-2006
Series:From the Cover
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:μ Opioid receptors are critical for heroin dependence, and A118G SNP of the μ opioid receptor gene (OPRM1) has been linked with heroin abuse. In our population of European Caucasians (n = 118), ≈90% of 118G allelic carriers were heroin users. Postmortem brain analyses showed the OPRM1 genotype associated with transcription, translation, and processing of the human striatal opioid neuropeptide system. Whereas down-regulation of preproenkephalin and preprodynorphin genes was evident in all heroin users, the effects were exaggerated in 118G subjects and were most prominent for preproenkephalin in the nucleus accumbens shell. Reduced opioid neuropeptide transcription was accompanied by increased dynorphin and enkephalin peptide concentrations exclusively in 118G heroin subjects, suggesting that the peptide processing is associated with the OPRM1 genotype. Abnormal gene expression related to peptide convertase and ubiquitin/proteosome regulation was also evident in heroin users. Taken together, alterations in opioid neuropeptide systems might underlie enhanced opiate abuse vulnerability apparent in 118G individuals.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: A.N., E.K., and Y.L.H. designed research; K.D., A.N., M.C.H., P.F., A.G., K.S., S.R., J.R., and E.K. performed research; I.N. and G.B. contributed new reagents/analytic tools; K.D., A.N., M.C.H., P.F., A.G., K.S., and Y.L.H. analyzed data; and K.D., P.F., and Y.L.H. wrote the paper.
Edited by L. L. Iversen, University of Oxford, Oxford, United Kingdom, and approved April 7, 2006
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.0600871103